Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123459834 | 12345983 | 4 | F | 20150212 | 20160907 | 20160509 | 20160909 | EXP | PHHY2015CA017683 | NOVARTIS | 61.34 | YR | M | Y | 0.00000 | 20160909 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123459834 | 12345983 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | QD | |||||||
| 123459834 | 12345983 | 2 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 123459834 | 12345983 | 3 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 123459834 | 12345983 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 123459834 | 12345983 | 5 | C | IRON | IRON | 1 | Unknown | UNK, TID | U | 0 | TID | ||||||||
| 123459834 | 12345983 | 6 | C | COLACE | DOCUSATE SODIUM | 1 | Unknown | UNK, PRN | U | 0 | |||||||||
| 123459834 | 12345983 | 7 | C | IRON SULFATE | FERROUS SULFATE ANHYDROUS | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123459834 | 12345983 | 1 | Gastrointestinal stromal tumour |
| 123459834 | 12345983 | 2 | Product used for unknown indication |
| 123459834 | 12345983 | 3 | Product used for unknown indication |
| 123459834 | 12345983 | 4 | Product used for unknown indication |
| 123459834 | 12345983 | 5 | Product used for unknown indication |
| 123459834 | 12345983 | 6 | Product used for unknown indication |
| 123459834 | 12345983 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123459834 | 12345983 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123459834 | 12345983 | Anal pruritus | |
| 123459834 | 12345983 | Anorectal discomfort | |
| 123459834 | 12345983 | Anorectal disorder | |
| 123459834 | 12345983 | Blood pressure decreased | |
| 123459834 | 12345983 | Burning sensation | |
| 123459834 | 12345983 | Dry skin | |
| 123459834 | 12345983 | Fatigue | |
| 123459834 | 12345983 | Feeling hot | |
| 123459834 | 12345983 | Nasopharyngitis | |
| 123459834 | 12345983 | Peripheral coldness | |
| 123459834 | 12345983 | Proctalgia | |
| 123459834 | 12345983 | Prostate cancer | |
| 123459834 | 12345983 | Prostatic specific antigen increased | |
| 123459834 | 12345983 | Pruritus | |
| 123459834 | 12345983 | Rash | |
| 123459834 | 12345983 | Rash pruritic | |
| 123459834 | 12345983 | Scratch | |
| 123459834 | 12345983 | Second primary malignancy | |
| 123459834 | 12345983 | Temperature intolerance | |
| 123459834 | 12345983 | Wound | |
| 123459834 | 12345983 | Wound infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123459834 | 12345983 | 1 | 20150209 | 0 |